Prevention & Chronic Conditions

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

Cardiovascular Risk in NAFLD

Published:

09 May 2024

Citation:

European Cardiology Review 2024;19:e02.

Spironolactone versus Eplerenone for Resistant Hypertension

Published:

24 April 2024

Citation:

Journal of Asian Pacific Society of Cardiology 2024;3:e12.

The QFR-DECISION-PCI Study

Published:

10 April 2024

Citation:

Journal of Asian Pacific Society of Cardiology 2024;3:e08.

Dual-pathway Inhibition versus Aspirin Monotherapy

Published:

05 April 2024

Citation:

European Cardiology Review 2024;19:e01.